METASTATIC RENAL CELL CARCINOMA
Clinical trials for METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer patients with bone metastases: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called zanzalintinib, taken with a bone-strengthening agent, in 20 people whose kidney cancer has spread to the bones and has worsened after prior immunotherapy. The goal is to see if this combination can stop the cancer from growing for at least 12 mo…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Kelly Fitzgerald, MD • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Cold sore virus modified to fight kidney cancer in new trial
Disease control Not yet recruitingThis study tests a new treatment for advanced kidney cancer that has spread and worsened after immunotherapy. The treatment combines a modified cold sore virus (RP2) that attacks tumor cells and activates the immune system, with a targeted drug (tivozanib) that blocks tumor growt…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Could a fake fast boost kidney cancer treatment?
Disease control Not yet recruitingThis study tests whether a 5-day fasting-mimicking diet can improve the effectiveness and safety of standard first-line drugs (toripalimab plus axitinib) for people with advanced kidney cancer that has spread or cannot be removed. About 43 adults with clear cell renal cell carcin…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: NA • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC